Given that SGLT2 transporters are upregulated under systemic hyperglycemia and insulin resistance, and that THCV improves these, it may be useful to analyze its effect on renal glucose reabsorption in the setting of elevated serum glucose and insulin. Here, SLC5A2 is linked to Insulin resistance.